Beijing Showby Pharmaceutical Co., Ltd.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jul 2032
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Mar 22, 2027The maintenance fee for Platinum compounds for treating cell proliferative diseases, preparation method and use thereof (US 9,138,421) comes due Mar 22, 2027. Unpaid by Sep 22, 2027, it lapses early.
- 1 fee due May 3, 2027The maintenance fee for Platinum compound having amino or alkylamino-containing succinic acid derivatives as leaving group, preparation method thereof, and use thereof (US 9,175,024) comes due May 3, 2027. Unpaid by Nov 3, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 7 of 7
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,138,421 | Platinum compounds for treating cell proliferative diseases, preparation method and use thereof In force · USPTO record | In force | USPTO record | |
| US 9,175,024 | Platinum compound having amino or alkylamino-containing succinic acid derivatives as leaving group, preparation method thereof, and use thereof In force · USPTO record | In force | USPTO record | |
| US 9,725,477 | Platinum compounds of malonic acid derivative having leaving group containing amino or alkylamino In force · USPTO record | In force | USPTO record | |
| US 9,751,875 | Quinine compounds, and optical isomers, preparation method and medical use thereof In force · USPTO record | In force | USPTO record | |
| US 11,447,485 | Class of bifunctional compounds with quanternary ammonium salt structure In force · USPTO record | In force | USPTO record | |
| US 11,661,434 | Phosphate of Platinum Compound and Preparation Method Therefor In force · High confidence | In force | High confidence | |
| US 12,358,908 | Crystals, Preparation Method and Application of a Muscarinic Receptor Antagonist In force · High confidence | In force | High confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
Every application published under this name has become a patent.